DUBLIN--(
BUSINESS WIRE
)--The
"Specialty PACS Market Analysis by Type, by Component, by Deployment Model, End user and by Region - Global Forecast to 2029"
report has been added to
ResearchAndMarkets.com's
offering.
The specialty PACS market size is estimated to be USD 2.9 billion in 2021 and is expected to witness a CAGR of 8.62% during the forecast period 2022-2029.
The growing geriatric population and consequent increase in the incidence of various diseases, benefits associated with specialty PACS, government efforts boost the acceptance of healthcare IT solutions, rising investments in medical imaging, increased adoption of medical imaging IT solutions, and expanding use of imaging equipment are some of the key drivers for the market growth. However, budgeting restrictions are expected to restrain the market growth.
Companies Mentioned
IBM Corporation (Merge Healthcare Incorporated) (US)
McKesson Corporation (US)
Agfa Healthcare (Belgium)
Carestream Health (a part of Onex Corporation) (Canada)
Philips Healthcare (Netherlands)
Sectra AB (Sweden)
Siemens Healthineers (Germany)
Novarad (US)
INFINITT North America (US)
Intelerad Medical Systems (Canada)
Topcon Corporation (Japan)
Sonomed Escalon (US)
Canon USA Inc. (US) (a subsidiary of Canon Inc.)
Visbion (UK)
EyePACS LLC (US)
Market Segmentation:
By Type (Revenue, USD Billion)
Radiology PACS
Ophthalmology PACS
Endoscopy PACS
Women's Health PACS
Oncology PACS
Orthopaedics PACS
Pathology PACS
Dermatology PACS
Neurology PACS
Others
By Component (Revenue, USD Billion)
Software
Services
Hardware
By Deployment Model (Revenue, USD Billion)
Cloud-based
On-premise
By End user (Revenue, USD Billion)
Ambulatory Surgery Centres
Diagnostic Imaging Centres
Hospitals
Others
By Region (Revenue, USD Billion)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit
https://www.researchandmarkets.com/r/a1cimr